JPH0625000A - Protease inhibitor - Google Patents

Protease inhibitor

Info

Publication number
JPH0625000A
JPH0625000A JP4073842A JP7384292A JPH0625000A JP H0625000 A JPH0625000 A JP H0625000A JP 4073842 A JP4073842 A JP 4073842A JP 7384292 A JP7384292 A JP 7384292A JP H0625000 A JPH0625000 A JP H0625000A
Authority
JP
Japan
Prior art keywords
protease
extract
protease inhibitor
plant
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4073842A
Other languages
Japanese (ja)
Other versions
JP3159509B2 (en
Inventor
Hirohisa Suidou
裕久 水道
Yuka Ogawa
由華 小川
Hidehiko Otsuki
秀彦 大槻
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunstar Inc
Original Assignee
Sunstar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunstar Inc filed Critical Sunstar Inc
Priority to JP07384292A priority Critical patent/JP3159509B2/en
Publication of JPH0625000A publication Critical patent/JPH0625000A/en
Application granted granted Critical
Publication of JP3159509B2 publication Critical patent/JP3159509B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE:To provide a protease inhibitor useful for preventing or improving periodontosis and capable of inhibiting the activity of protease. CONSTITUTION:This invented protease inhibitor contains one or more kinds of plants selected from a group of Allium, Citrus reticulate Blanco, Glycyrrhiza glabra L., Matricaria chamomilla L., Plantago psyllium L., Platycodon grandiflorum, cinnamon, Foeniculum vulgare Mill., hop, Valerianae faurier Brig. radix, Scutellaria baicalensis, Lithospermum erythrorhizon, Salvia miltiorrhiza Bunge, ginkgo, bamboo and Morus alba or solvent extracts thereof as the active components.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、新規なプロテアーゼ阻
害剤に関する。さらに詳しくは、歯肉炎、歯槽膿漏など
歯周病の予防あるいは治療に有用な、歯周病原性細菌が
産生するプロテアーゼの活性を阻害する新規プロテアー
ゼ阻害剤に関する。
FIELD OF THE INVENTION The present invention relates to novel protease inhibitors. More specifically, the present invention relates to a novel protease inhibitor that is useful for the prevention or treatment of periodontal diseases such as gingivitis and periodontal pyorrhea and that inhibits the activity of protease produced by periodontopathic bacteria.

【0002】[0002]

【従来の技術および課題】近年、歯周病は、歯肉溝内の
ある種のグラム陰性嫌気性細菌に起因することが明らか
になり、その原因菌の代表的なものとしてポルフィロモ
ナス・ジンジバリス(旧名バクテロイデス・ジンジバリ
ス)やトレポネマ・デンティコラが挙げられている。こ
れら原因菌は歯周局所に棲息し、コラゲナーゼ、トリプ
シン様酵素などこれら病原菌に特異的なプロテアーゼを
産生し、これらのプロテアーゼが歯周組織の破壊など歯
周病の発症と密接に関係するといわれている[ジャーナ
ル・オブ・デンタル・リサーチ(J.Dent.Res.)
63,412−421,1984およびジャーナル・オ
ブ・デンタル・リサーチ 65,1335−1340,
1986]。したがって、歯周病を予防または治療する
手段として、これらのプロテアーゼの作用を阻害するこ
とが非常に有効な方法であると考えられる。
2. Description of the Related Art Recently, periodontal disease has been revealed to be caused by a certain Gram-negative anaerobic bacterium in the gingival sulcus, and Porphyromonas gingivalis ( Formerly known as Bacteroides gingivalis) and Treponema denticola are listed. It is said that these causative bacteria inhabit the periodontal tissues and produce proteases specific to these pathogens such as collagenase and trypsin-like enzyme, and these proteases are closely related to the development of periodontal disease such as the destruction of periodontal tissues. [Journal of Dental Research (J.Dent.Res.)
63, 412-421, 1984 and Journal of Dental Research 65, 1335-1340,
1986]. Therefore, it is considered that inhibiting the action of these proteases is a very effective method as a means for preventing or treating periodontal disease.

【0003】しかしながら、これまで、このようなプロ
テアーゼの活性に注目し、その酵素活性を阻害すること
により、歯周病を予防または治療することについての提
案は何ら見当たらない。また、従来から、ロイペプチン
やアンチパインなどのプロテアーゼ阻害剤が知られてい
るが、安全性の点で問題があり、医薬品、医薬部外品ま
たは化粧品として実用化されていないのが現状である。
However, up to now, no proposal has been found to prevent or treat periodontal disease by paying attention to the activity of such protease and inhibiting the enzyme activity. In addition, conventionally, protease inhibitors such as leupeptin and antipain have been known, but there is a problem in terms of safety, and at present, they are not put into practical use as pharmaceuticals, quasi drugs or cosmetics.

【0004】[0004]

【課題を解決するための手段】本発明は、公知のプロテ
アーゼ阻害剤の満足できない点を考慮し、安全性が高く
真にプロテアーゼ阻害効果に優れた薬剤を得るべく鋭意
研究を重ねた結果、ある種の植物抽出エキスがプロテア
ーゼ阻害作用という新規な活性を有することを見い出
し、本発明を完成するに至った。
Means for Solving the Problems The present invention has been made as a result of earnest studies to obtain a drug having a high safety and a truly excellent protease inhibitory effect in consideration of the unsatisfactory point of known protease inhibitors. The present inventors have found that a plant extract of a seed has a novel activity called a protease inhibitory action, and completed the present invention.

【0005】すなわち、本発明は、ニンニク、チンピ、
カンゾウ、カミツレ、シャゼンソウ、キキョウ、ケイ
ヒ、ウイキョウ、ホップ、カノコソウ、オウゴン、シコ
ン、セージ、イチョウ、竹およびソウハクヒからなる群
より選ばれる1種または2種以上の植物、または該植物
の溶媒抽出エキスを有効成分とすることを特徴とするプ
ロテアーゼ阻害剤を提供するものである。
That is, the present invention relates to garlic, chimpi,
One or more kinds of plants selected from the group consisting of licorice, chamomile, chamomile, zelkova, cinnamon, fennel, hops, valerian, staghorn, sikhon, sage, ginkgo, bamboo and sakuhaku, or a solvent-extracted extract of the plant. The present invention provides a protease inhibitor characterized by being an active ingredient.

【0006】本発明において用いる植物は、その部位や
形態は特に限定するものではないが、通常、植物自体を
乾燥し粉砕した乾燥粉末の形態のものを用いることが好
ましい。また、植物溶媒抽出エキスは、自体公知の抽出
操作に従って、例えば、前記植物あるいはその乾燥粉末
を水もしくは有機溶媒、例えば、メタノール、エタノー
ル、n−プロパノール、ブタノール、アセトン、ピリジ
ン、ポリエチレングリコール、プロピレングリコール、
クロロホルム、酢酸エチル、エーテル、ベンゼン、トル
エン、シクロヘキサン、四塩化炭素などで抽出し、濃縮
し、乾燥することにより得ることができる。
The plant used in the present invention is not particularly limited in its part or form, but it is usually preferable to use a dry powder form obtained by drying and crushing the plant itself. In addition, the plant solvent extraction extract may be prepared by subjecting the plant or its dry powder to water or an organic solvent such as methanol, ethanol, n-propanol, butanol, acetone, pyridine, polyethylene glycol or propylene glycol, according to an extraction operation known per se. ,
It can be obtained by extraction with chloroform, ethyl acetate, ether, benzene, toluene, cyclohexane, carbon tetrachloride, etc., concentration, and drying.

【0007】本発明のプロテアーゼ阻害剤は常法に従っ
て、練歯磨、粉歯磨、液状歯磨、マウスウォッシュ、パ
スタ、クリーム、うがい液、トローチ、キャンディ、チ
ューインガム、軟膏剤、貼付剤、錠剤等の組成物とする
ことができる。本発明においては、該植物乾燥粉末ある
いは溶媒抽出エキスを単独であるいは2種以上を組み合
わせて用いることができ、プロテアーゼ阻害剤全量に対
し乾燥重量として0.0001〜30重量%、好ましく
は0.001〜5重量%配合することにより、所望の効
果が得られる。他の配合成分は、特に限定するものでは
なく、通常、この種の組成物に用いられるいずれの成分
も配合することができる。
The protease inhibitor of the present invention is a composition such as toothpaste, powder toothpaste, liquid toothpaste, mouthwash, pasta, cream, mouthwash, troche, candy, chewing gum, ointment, patch, tablet, etc., according to a conventional method. Can be In the present invention, the plant dry powder or the solvent-extracted extract can be used alone or in combination of two or more kinds, and the dry weight is 0.0001 to 30% by weight, preferably 0.001 with respect to the total amount of the protease inhibitor. A desired effect can be obtained by blending 5% by weight. The other compounding ingredients are not particularly limited, and any ingredient usually used in this type of composition can be compounded.

【0008】さらに、これら組成物に他の薬効成分、た
とえばクロルヘキシジン、トリクロサン、塩化セチルピ
リジニウムなどの殺菌剤や抗菌性のある植物成分等を適
量配合することにより歯周病の予防あるいは治療効果を
一層高めることができる。
[0008] Furthermore, by further adding other medicinal components, such as chlorhexidine, triclosan, cetylpyridinium chloride, and other fungicides and antibacterial plant components, to these compositions, the effect of preventing or treating periodontal disease is further enhanced. Can be increased.

【0009】[0009]

【実施例】次に、実施例および試験例を挙げて本発明を
さらに詳しく説明する。 実施例1 植物抽出エキスの調製 乾燥し、粉砕した各植物粉末10gに水、メタノールま
たはこれらの混液を加え、加熱還流下にて2時間抽出を
行った。抽出液を減圧濃縮後、乾燥し、所望の植物抽出
エキスを得た。
EXAMPLES The present invention will be described in more detail with reference to Examples and Test Examples. Example 1 Preparation of plant extract Extract 10 g of each dried and pulverized plant powder was added with water, methanol or a mixed solution thereof, and extracted under heating and refluxing for 2 hours. The extract was concentrated under reduced pressure and then dried to obtain the desired plant extract.

【0010】実施例2 練歯磨 次の処方により、常法に従って練歯磨を製造した。 成分 配合量(重量%) 無水ケイ酸 15 ラウリル硫酸ナトリウム 1 ポリアクリル酸 1 ソルビット(70%溶液) 60 カラギーナン 0.2 シャゼンソウエキス 0.01 ケイヒエキス 0.01 サッカリンナトリウム 0.2 防腐剤および香料 1.2 蒸留水 100%に調整Example 2 Toothpaste A toothpaste was produced according to a conventional method according to the following formulation. Ingredients Amount (% by weight) Silicic anhydride 15 Sodium lauryl sulphate 1 Polyacrylic acid 1 Sorbit (70% solution) 60 Carrageenan 0.2 Chalazion extract 0.01 Cayhi extract 0.01 Sodium saccharin 0.2 Preservatives and fragrances 1.2 Distilled water adjusted to 100%

【0011】実施例3 マウスウオッシュ 次の処方により、常法に従ってマウスウオッシュを製造
した。 成分 配合量(重量%) エタノール 5 ソルビット(70%溶液) 15 ポリオキシエチレン(60EO)硬化ヒマシ油 0.5 モノオレイン酸ポリオキシエチレン(20EO)ソルビタン 0.5 ウイキョウエキス 0.05 サッカリンナトリウム 0.1 防腐剤および香料 0.8 蒸留水 100%に調整
Example 3 Mouthwash A mousewash was produced according to a conventional method according to the following formulation. Ingredients Amount (wt%) Ethanol 5 Solbit (70% solution) 15 Polyoxyethylene (60EO) hydrogenated castor oil 0.5 Polyoxyethylene monooleate (20EO) sorbitan 0.5 Fennel extract 0.05 Saccharin sodium 0.1 Preservative and fragrance 0.8 Adjusted to 100% distilled water

【0012】実施例4 マウスウオッシュ 次の処方により、常法に従ってマウスウオッシュを製造
した。 成分 配合量(重量%) エタノール 15 グリセリン 15 ポリオキシエチレン(60EO)硬化ヒマシ油 1 カノコソウエキス 0.05 塩化セチルピリジニウム 0.05 サッカリンナトリウム 0.1 香料 0.5 蒸留水 100%に調整
Example 4 Mouthwash A mousewash was produced by the following method according to a conventional method. Ingredients Amount (% by weight) Ethanol 15 Glycerin 15 Polyoxyethylene (60EO) hydrogenated castor oil 1 Valerian extract 0.05 Cetylpyridinium chloride 0.05 Saccharin sodium 0.1 Perfume 0.5 Distilled water 100% adjusted

【0013】実施例5 口腔内パスタ 次の処方により、常法に従って口腔内パスタを製造し
た。 成分 配合量(重量%) 白色ワセリン 10.0 ステアリンアルコール 8.0 プロピレングリコール 5.6 ラウリル硫酸ナトリウム 0.6 パラオキシ安息香酸エチル 0.01 蒸留水 16.1 ソウハクヒエキス 1.0 カルボキシメチルセルロースナトリウム 100%に調整
Example 5 Oral pasta An oral pasta was produced according to a conventional method according to the following formulation. Ingredients Amount (wt%) White petrolatum 10.0 Stearic alcohol 8.0 Propylene glycol 5.6 Sodium lauryl sulphate 0.6 Ethyl paraoxybenzoate 0.01 Distilled water 16.1 Sohakuhi extract 1.0 Carboxymethylcellulose sodium 100% Adjusted to

【0014】実施例6 ハードキャンディ 次の処方により、常法に従ってハードキャンディを製造
した。 成分 配合量(重量%) グラニュー糖 46.8 水飴 52.37 クエン酸 0.3 チンピエキス 0.03 l−メントール 0.5 合計 100.0
Example 6 Hard Candy A hard candy was produced by the following method according to a conventional method. Ingredients Amount (% by weight) Granulated sugar 46.8 Starch syrup 52.37 Citric acid 0.3 Chimp extract 0.03 l-menthol 0.5 Total 100.0

【0015】試験例1 実施例1の方法に従って調製した各植物抽出エキスのプ
ロテアーゼ阻害活性について検討した。 (1)プロテアーゼの調製 ポルフィロモナス・ジンジバリス381株をブレイン・
ハート・インフュージョンブロス(0.5%酵母エキ
ス、5μg/mlヘミン、0.2μg/mlメナジオン
添加)で、37℃、48時間嫌気培養し、遠心分離(7
000rpm、10分間)に付し、培養上澄をプロテア
ーゼ粗酵素として以下の試験に供した。
Test Example 1 The protease inhibitory activity of each plant extract prepared according to the method of Example 1 was examined. (1) Preparation of Protease Porphyromonas gingivalis strain 381 strain
Anaerobically cultivated in heart infusion broth (0.5% yeast extract, 5 μg / ml hemin, 0.2 μg / ml menadione added) at 37 ° C. for 48 hours and centrifuged (7
The culture supernatant was subjected to the following test as a crude protease enzyme.

【0016】(2)基質溶液の調製 N−カルボベンゾキシ−グリシル−グリシル−アルギニ
ン−β−ナフチルアミドをジメチルスルホキシドで10
mMの濃度が得られるよう調整し、これを蒸留水で1m
Mに希釈したものを基質溶液とした。
(2) Preparation of substrate solution N-carbobenzoxy-glycyl-glycyl-arginine-β-naphthylamide was treated with dimethyl sulfoxide to give 10
Adjust to obtain mM concentration, and use distilled water for 1m
What was diluted to M was used as the substrate solution.

【0017】(3)プロテアーゼ活性の測定 試験管(内径12mm、長さ100mm)に1mMの基
質溶液0.3ml、0.1MのTris−HCl緩衝液(p
H7.0)0.9ml、種々の濃度の植物抽出エキスあ
るいは蒸留水0.3mlを入れ反応溶液とし、これに上
記プロテアーゼ粗酵素0.3mlを加え、37℃、1時
間インキュベーションを行った。終了時、0.5mg/
ml Fast Garnet GBC(10% Tween20を含
む1M酢酸緩衝液、pH4.2に溶解したもの)0.6
mlを加え、室温で15分以上放置した後、525nm
における吸光度を分光光度計(Perkin−Elmer, Mode
l 55B)を用いて測定した。被験植物エキスを用いた
場合の酵素活性(ΔOD525)をa、蒸留水を用いた場
合の酵素活性をbとした場合、各植物エキス抽出エキス
試料のプロテアーゼ阻害率(%)を次式より算出した。
(3) Measurement of protease activity In a test tube (inner diameter 12 mm, length 100 mm), 0.3 ml of 1 mM substrate solution and 0.1 M Tris-HCl buffer solution (p
H7.0) 0.9 ml and plant extract of various concentrations or 0.3 ml of distilled water was added to make a reaction solution, and 0.3 ml of the above protease crude enzyme was added thereto and incubated at 37 ° C. for 1 hour. At the end, 0.5 mg /
ml Fast Garnet GBC (1 M acetate buffer containing 10% Tween 20, dissolved in pH 4.2) 0.6
After adding 15 ml and leaving at room temperature for 15 minutes or more, 525 nm
Absorbance at a spectrophotometer (Perkin-Elmer, Mode
55B). When the enzyme activity (ΔOD 525 ) when using the test plant extract is a and the enzyme activity when using distilled water is b, the protease inhibition rate (%) of each plant extract extract extract is calculated from the following formula. did.

【0018】[0018]

【数1】 [Equation 1]

【0019】その結果を表1に示す。The results are shown in Table 1.

【表1】 [Table 1]

【0020】表1から明らかなように、各植物エキスは
0.1%の濃度で61〜99%、0.01%濃度で22
〜98%の阻害率を示した。特に、陽性対照として用い
たロイペプチンの阻害率(0.1%濃度で95%、0.
01%濃度で50%)と同等もしくはそれ以上の阻害率
を示した植物エキスは、チンピ、シャゼンソウ、ケイ
ヒ、カノコソウ、竹、ソウハクヒの各エキスであった。
As is clear from Table 1, each plant extract had a concentration of 61% to 99% at a concentration of 0.1% and 22% at a concentration of 0.01%.
It showed an inhibition rate of ˜98%. In particular, the inhibition rate of leupeptin used as a positive control (95% at 0.1% concentration, 0.
The plant extracts exhibiting an inhibition rate equal to or higher than 50% at a concentration of 01%) were extracts of Chinpi, Chazensou, Keihi, Kanokoso, Bamboo, and Sakuhaku.

【0021】試験例2 歯周病患者の歯周局所より分離したトレポネマ・デンテ
ィコラの1菌株をTYGVS培地で37℃、1週間嫌気
培養した培養菌液(濁度がOD660=0.5となるよう
同培地で調製したもの)を酵素液とし、シャゼンソウエ
キスおよびソウハクヒエキスの種々の濃度におけるプロ
テアーゼ阻害活性について検討した。基質溶液の調製お
よびプロテアーゼ活性の測定法は試験例1に準じて行っ
た。その結果を表2に示す。
Test Example 2 A strain of Treponema denticola isolated from the periodontal region of a patient with periodontal disease was anaerobically cultivated in TYGVS medium at 37 ° C. for 1 week (a turbidity is OD 660 = 0.5). The enzyme inhibitory solution prepared by the same culture medium) was used as an enzyme solution, and the protease inhibitory activity of various concentrations of the Chazensou extract and the Sohakuhi extract was examined. The substrate solution was prepared and the protease activity was measured according to Test Example 1. The results are shown in Table 2.

【0022】[0022]

【表2】 [Table 2]

【0023】表2に示すように、いずれの植物エキスも
0.0001%の濃度で10%以上の阻害率、0.00
1%以上の濃度では50%以上の阻害率を示した。
As shown in Table 2, each plant extract had an inhibition rate of 10% or more at a concentration of 0.0001%, and
At a concentration of 1% or more, an inhibition rate of 50% or more was shown.

【0024】[0024]

【発明の効果】本発明によれば、プロテアーゼを強力か
つ有効に阻害し、歯周病の予防あるいは治療に非常に有
用であるだけでなく、かつ、有効成分が天然物であるた
め、副作用もなく、安全性面で非常に優れているプロテ
アーゼ阻害剤を得ることができる。
INDUSTRIAL APPLICABILITY According to the present invention, not only is it a strong and effective inhibitor of protease and is very useful for the prevention or treatment of periodontal disease, but also the active ingredient is a natural product, so that there are no side effects. And a protease inhibitor which is very excellent in safety can be obtained.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 ニンニク、チンピ、カンゾウ、カミツ
レ、シャゼンソウ、キキョウ、ケイヒ、ウイキョウ、ホ
ップ、カノコソウ、オウゴン、シコン、セージ、イチョ
ウ、竹およびソウハクヒからなる群より選ばれる1種ま
たは2種以上の植物、または該植物の溶媒抽出エキスを
有効成分とすることを特徴とするプロテアーゼ阻害剤。
1. One or more kinds of plants selected from the group consisting of garlic, chinpi, licorice, chamomile, chamomile, cypress, cinnamon, fennel, hops, valerian, corn, sage, sage, ginkgo, bamboo and sakuhaku. Or a protease inhibitor comprising a solvent-extracted extract of the plant as an active ingredient.
JP07384292A 1992-03-30 1992-03-30 Protease inhibitor Expired - Lifetime JP3159509B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP07384292A JP3159509B2 (en) 1992-03-30 1992-03-30 Protease inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP07384292A JP3159509B2 (en) 1992-03-30 1992-03-30 Protease inhibitor

Publications (2)

Publication Number Publication Date
JPH0625000A true JPH0625000A (en) 1994-02-01
JP3159509B2 JP3159509B2 (en) 2001-04-23

Family

ID=13529802

Family Applications (1)

Application Number Title Priority Date Filing Date
JP07384292A Expired - Lifetime JP3159509B2 (en) 1992-03-30 1992-03-30 Protease inhibitor

Country Status (1)

Country Link
JP (1) JP3159509B2 (en)

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07309733A (en) * 1994-05-19 1995-11-28 Kanebo Ltd Composition for oral cavity
JPH07316064A (en) * 1993-11-10 1995-12-05 Morishita Jintan Kk Suppressor for causative of periodontal disease or caries and composition for oral cavity and food containing the same
JPH1045550A (en) * 1996-07-25 1998-02-17 Lg Chem Ltd Oral hygiene-promoting composition
WO1998016239A1 (en) * 1996-10-14 1998-04-23 Korea Institute Of Science And Technology CITRUS PEEL EXTRACT AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR
NL1005193C2 (en) * 1997-02-05 1998-08-06 Biodent B V Compositions containing plant-derived protease inhibitors
JPH10291929A (en) * 1997-04-21 1998-11-04 Nagase & Co Ltd Wrinkle suppressive preparation for external use for skin
JPH11139947A (en) * 1997-11-11 1999-05-25 Sunstar Inc Composition containing matrix metalloprotease inhibitor and used for oral cavity
JPH11147834A (en) * 1997-11-18 1999-06-02 Noevir Co Ltd Serine protease inhibitor
JPH11279039A (en) * 1998-03-31 1999-10-12 Saiseido Yakuhin Kk Composition for oral cavity
EP0958833A1 (en) * 1998-05-20 1999-11-24 Erasmus Universiteit Rotterdam Methods and means for preventing or treating inflammation
JP2000226324A (en) * 1998-11-30 2000-08-15 Kansai Koso Kk Liquid agent composition for cleaning/wiping and for cosmetic water
JP2001089385A (en) * 1999-09-22 2001-04-03 Kobayashi Pharmaceut Co Ltd Anti-dental caries agent
JP2002003353A (en) * 2000-06-19 2002-01-09 Kansai Koso Kk Methionase and/or protease inhibitor and composition for oral cavity
JP2003160459A (en) * 2001-11-22 2003-06-03 Kansai Koso Kk Methionase activity inhibitor and composition for oral cavity
JP2003183122A (en) * 2001-12-21 2003-07-03 Ichimaru Pharcos Co Ltd Agent for inhibiting activity of collagenase
JP2004123630A (en) * 2002-10-03 2004-04-22 Chisso Corp Cariostatic and antiperiodontic composition
JP2004231602A (en) * 2003-01-31 2004-08-19 Hideji Watanabe Buccal composition containing galenical extract having antioxidation activity
JP2005008541A (en) * 2003-06-18 2005-01-13 Akita Prefecture Collagenase inhibitor and food containing the same
JP2006199661A (en) * 2005-01-24 2006-08-03 Sunstar Inc Coaggregation inhibitor
JP2006306832A (en) * 2005-03-31 2006-11-09 Kobayashi Pharmaceut Co Ltd Inhibitor of gingival epithelial cell extension
JP2009280613A (en) * 2009-08-31 2009-12-03 Shiseido Co Ltd Plasmin specific activity inhibitor
JP2011256136A (en) * 2010-06-09 2011-12-22 Nihon Univ Collagen decomposition inhibitor
JP2012214402A (en) * 2011-03-31 2012-11-08 Kobayashi Pharmaceutical Co Ltd Composition for oral cavity
JP2015054847A (en) * 2013-09-13 2015-03-23 一丸ファルコス株式会社 Periodontal disease bacterial inhibitor
KR101520821B1 (en) * 2012-11-01 2015-05-15 주식회사 벤스랩 Composition for preventing and alleviating periodontal diseases and manufacturing method thereof
JP2017039703A (en) * 2015-08-17 2017-02-23 御木本製薬株式会社 Kallikrein-related peptidase production promoter, lekti production promoter, slpi production promoter, keratinization normalizer, and corneodesmosomal degradation normalizer
WO2017199453A1 (en) 2016-05-18 2017-11-23 日本ゼトック株式会社 Composition for oral cavity
WO2018003134A1 (en) * 2016-06-28 2018-01-04 日本ゼトック株式会社 Composition for use in oral cavity
JP2022079676A (en) * 2017-08-30 2022-05-26 丸善製薬株式会社 Type i collagen production promoter and oral agent in normal human gingival fibroblast

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07316064A (en) * 1993-11-10 1995-12-05 Morishita Jintan Kk Suppressor for causative of periodontal disease or caries and composition for oral cavity and food containing the same
JPH07309733A (en) * 1994-05-19 1995-11-28 Kanebo Ltd Composition for oral cavity
JPH1045550A (en) * 1996-07-25 1998-02-17 Lg Chem Ltd Oral hygiene-promoting composition
WO1998016239A1 (en) * 1996-10-14 1998-04-23 Korea Institute Of Science And Technology CITRUS PEEL EXTRACT AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR
NL1005193C2 (en) * 1997-02-05 1998-08-06 Biodent B V Compositions containing plant-derived protease inhibitors
JPH10291929A (en) * 1997-04-21 1998-11-04 Nagase & Co Ltd Wrinkle suppressive preparation for external use for skin
JPH11139947A (en) * 1997-11-11 1999-05-25 Sunstar Inc Composition containing matrix metalloprotease inhibitor and used for oral cavity
JPH11147834A (en) * 1997-11-18 1999-06-02 Noevir Co Ltd Serine protease inhibitor
JPH11279039A (en) * 1998-03-31 1999-10-12 Saiseido Yakuhin Kk Composition for oral cavity
EP0958833A1 (en) * 1998-05-20 1999-11-24 Erasmus Universiteit Rotterdam Methods and means for preventing or treating inflammation
WO1999059623A1 (en) * 1998-05-20 1999-11-25 Erasmus Universiteit Rotterdam Methods and means for preventing or treating inflammation or pruritis
JP2002515454A (en) * 1998-05-20 2002-05-28 エラスムス ユニフェルシテイト ロッテルダム Method and means for preventing or treating inflammation or pruritus
US6723354B1 (en) 1998-05-20 2004-04-20 Erasmus Universiteit Rotterdam Methods and means for preventing or treating inflammation or pruritis
JP2000226324A (en) * 1998-11-30 2000-08-15 Kansai Koso Kk Liquid agent composition for cleaning/wiping and for cosmetic water
JP2001089385A (en) * 1999-09-22 2001-04-03 Kobayashi Pharmaceut Co Ltd Anti-dental caries agent
JP2002003353A (en) * 2000-06-19 2002-01-09 Kansai Koso Kk Methionase and/or protease inhibitor and composition for oral cavity
JP2003160459A (en) * 2001-11-22 2003-06-03 Kansai Koso Kk Methionase activity inhibitor and composition for oral cavity
JP2003183122A (en) * 2001-12-21 2003-07-03 Ichimaru Pharcos Co Ltd Agent for inhibiting activity of collagenase
JP2004123630A (en) * 2002-10-03 2004-04-22 Chisso Corp Cariostatic and antiperiodontic composition
JP2004231602A (en) * 2003-01-31 2004-08-19 Hideji Watanabe Buccal composition containing galenical extract having antioxidation activity
JP2005008541A (en) * 2003-06-18 2005-01-13 Akita Prefecture Collagenase inhibitor and food containing the same
JP2006199661A (en) * 2005-01-24 2006-08-03 Sunstar Inc Coaggregation inhibitor
JP2006306832A (en) * 2005-03-31 2006-11-09 Kobayashi Pharmaceut Co Ltd Inhibitor of gingival epithelial cell extension
JP2009280613A (en) * 2009-08-31 2009-12-03 Shiseido Co Ltd Plasmin specific activity inhibitor
JP2011256136A (en) * 2010-06-09 2011-12-22 Nihon Univ Collagen decomposition inhibitor
JP2012214402A (en) * 2011-03-31 2012-11-08 Kobayashi Pharmaceutical Co Ltd Composition for oral cavity
KR101520821B1 (en) * 2012-11-01 2015-05-15 주식회사 벤스랩 Composition for preventing and alleviating periodontal diseases and manufacturing method thereof
JP2015054847A (en) * 2013-09-13 2015-03-23 一丸ファルコス株式会社 Periodontal disease bacterial inhibitor
JP2017039703A (en) * 2015-08-17 2017-02-23 御木本製薬株式会社 Kallikrein-related peptidase production promoter, lekti production promoter, slpi production promoter, keratinization normalizer, and corneodesmosomal degradation normalizer
WO2017199453A1 (en) 2016-05-18 2017-11-23 日本ゼトック株式会社 Composition for oral cavity
US10603271B2 (en) 2016-05-18 2020-03-31 Nippon Zettoc Co., Ltd. Oral composition
WO2018003134A1 (en) * 2016-06-28 2018-01-04 日本ゼトック株式会社 Composition for use in oral cavity
JP2018002614A (en) * 2016-06-28 2018-01-11 日本ゼトック株式会社 Composition for oral cavity
JP2022079676A (en) * 2017-08-30 2022-05-26 丸善製薬株式会社 Type i collagen production promoter and oral agent in normal human gingival fibroblast

Also Published As

Publication number Publication date
JP3159509B2 (en) 2001-04-23

Similar Documents

Publication Publication Date Title
JPH0625000A (en) Protease inhibitor
US7083779B2 (en) Nontoxic dental care herbal formulation for preventing dental plaque and gingivitis
EP1649864B1 (en) Periodontal disease therapeutic and/or preventive composition
US20080138299A1 (en) Oral Pharmaceuticals or Oral Hygiene Products Comprising Licorice Flavonoid Extract
KR0176015B1 (en) Composition for prevention and treatment of periodontal disorders
HUE026862T2 (en) Combined plant extracts for use in the treatment of microbial infections
JP4873805B2 (en) Anti-periodontal agent
CN113559012A (en) Agilawood toothpaste with function of inhibiting oral helicobacter pylori
JP2848688B2 (en) Oral composition
Pandhi et al. Odontonutraceuticals: Phytochemicals for Oral Health Care
JPH11279039A (en) Composition for oral cavity
JP3008525B2 (en) Oral composition
Soundarajan et al. Antibacterial and anti-inflammatory effects of a novel herb-mediated nanocomposite mouthwash in plaque-induced gingivitis: a randomized controlled trial
Karic et al. Effectiveness of Allium sativum on bacterial oral infection
KR20110088978A (en) Oral composition containing herbal extract
JP2019196329A (en) Periodontal disease prevention oral composition
WO2019009663A1 (en) Composition for preventing and ameliorating athlete's foot
KR20030089047A (en) Composition for enhancing oral health
EP1641537B1 (en) Nontoxic dental care herbal formulation for preventing dental plaque and gingivitis
Alemeye et al. Antimicrobial activities and formulations of the extracts of chewing sticks commonly used in Ethiopia for oral cleansing
KR101025886B1 (en) Oral care compositions containing Alismae Rhizoma extract for preventing tooth decay
JPH07188045A (en) Antiplasmin agent
JPH0812586A (en) Antiplasmin agent
JP4515732B2 (en) Glucosyltransferase inhibitors, plaque formation inhibitors, antibacterial agents, oral preparations and foods for preventing touch
Théophile et al. Natural Chemical Compounds from Plants Extract for Prevention and Treatment of Oral Infections: A Review

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20010130

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090216

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090216

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100216

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110216

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110216

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120216

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120216

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130216

Year of fee payment: 12

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130216

Year of fee payment: 12